leadership

Angion’s leadership team has extensive experience
across the discovery, development, and commercialization
of therapeutics for kidney disease. Angion is applying its
deep scientific expertise to advance its pipeline to
treat life-threatening conditions.

OUR EXECUTIVE

MANAGEMENT TEAM

Jay Venkatesan, MD, MBA

President and Chief Executive Officer

Itzhak Goldberg, MD, FACR

Founder, Executive Chairman and Chief Scientific Officer

John F. Neylan, MD

Senior Vice President and Chief Medical Officer

Kevin Norrett, MBA

Senior Vice President and Chief Commercial Officer

Jennifer Rhodes

Senior Vice President and General Counsel